By Oluwole Fadare
This quantity offers a concise but entire assessment of precancerous lesions and gynecologic tract cancers. every one part discusses the ancient evolution of a precancerous lesion, its epidemiology, the character of the broadcast facts that helps its characterization as a precancerous lesion, and offers an in depth description of morphologic, immunophenotypic and molecular homes, and sufferer results. the quantity additionally good points 2 separate chapters at the scientific administration of precancerous lesions of the gynecologic tract as a good because the cytopathology of cervical precancerous lesions.
Lavishly illustrated and written by way of a number of the leading specialists within the box, Precancerous Lesions of the Gynecologic Tract: Diagnostic and Molecular Genetic Pathology is a definitive account of precancerous lesions of the gynecologic tract and is a invaluable source for pathologists, oncologists, and gynecologists.
Read Online or Download Precancerous Lesions of the Gynecologic Tract: Diagnostic and Molecular Genetic Pathology PDF
Best obstetrics & gynecology books
(Martin Dunitz) manhattan Univ. , manhattan urban. Atlas for postgraduates serious about the surgical administration of gynecological malignancy. contains a complete description of nearly all of investigative and surgeries required of the gynecological oncologist. provides transparent written and pictorial guideline.
The most efficient textual content in gynecology is in its Fourteenth version, completely revised and up-to-date and now in complete colour all through. geared up into 8 sections, this accomplished and common gynecological textbook offers suggestions for the administration of particular gynecological stipulations. the 1st sections conceal rules of perform and preliminary review and the proper simple technology.
This booklet brings jointly the main updated information regarding the body structure of progestogens. This quantity addresses the bidirectional conversation among hormones, fertility, tumors, and autoimmunity. It presents the fundamental technology and medical views of progestogens that have now not been formerly on hand in a single quantity.
This booklet addresses methodological points of epidemiological reports on maternal drug use in being pregnant. Discussing the prevailing assets of errors and the way they could produce fallacious conclusions, it examines a variety of epidemiological thoughts and assesses their strengths and weaknesses. those refer either to the id of results (with distinct emphasis on congenital malformations) and to the kinds of publicity (drug use).
Extra resources for Precancerous Lesions of the Gynecologic Tract: Diagnostic and Molecular Genetic Pathology
Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol. 2008;27(2):151–60. Slomovitz BM, Caputo TA, Gretz HF, Economos K, Tortoriello DV, Schlosshauer PW, et al. A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component. Am J Surg Pathol. 2002;26(5):592–600. Silva EG, Gershenson DM, Malpica A, Deavers M. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Obstet Gynecol. 1993;82(2):181–6. 23. Pothuri B, Leitao MM, Levine DA, Viale A, Olshen AB, Arroyo C, et al. Genetic analysis of the early natural history of epithelial ovarian carcinoma. PLoS One. 2010;5(4), e10358. 24. Clark-Knowles KV, Senterman MK, Collins O, Vanderhyden BC. Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas. PLoS One. 2009;4(12), e8534. 25. Perets R, Wyant GA, Muto KW, Bijron JG, Poole BB, Chin KT, et al. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.
2012;226(3):421–6. 69. Karst AM, Levanon K, Duraisamy S, Liu JF, Hirsch MS, Hecht JL, et al. Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas. Gynecol Oncol. 2011;123(1):5–12. 70. Levanon K, Sapoznik S, Bahar-Shany K, Brand H, Shapira-Frommer R, Korach J, et al. FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis. Oncogene. 2014;33(35):4424–32. 71. Roh MH, Yassin Y, Miron A, Mehra KK, Mehrad M, Monte NM, et al.